GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $10,554,000 | +12.1% | 242,444 | +12.2% | 0.02% | +20.0% |
Q1 2022 | $9,415,000 | -18.2% | 216,147 | -17.2% | 0.02% | -21.1% |
Q4 2021 | $11,512,000 | +16.3% | 261,040 | +0.8% | 0.02% | +5.6% |
Q3 2021 | $9,897,000 | -5.7% | 259,001 | -1.7% | 0.02% | -10.0% |
Q2 2021 | $10,493,000 | +12.9% | 263,480 | +1.2% | 0.02% | 0.0% |
Q1 2021 | $9,290,000 | +20.3% | 260,289 | +24.1% | 0.02% | +11.1% |
Q4 2020 | $7,720,000 | -2.0% | 209,794 | +0.3% | 0.02% | -14.3% |
Q3 2020 | $7,876,000 | -4.2% | 209,270 | +3.9% | 0.02% | -16.0% |
Q2 2020 | $8,218,000 | +10.4% | 201,472 | +2.5% | 0.02% | -13.8% |
Q1 2020 | $7,446,000 | -14.2% | 196,514 | +6.5% | 0.03% | -3.3% |
Q4 2019 | $8,675,000 | +4.9% | 184,606 | -4.8% | 0.03% | -3.2% |
Q3 2019 | $8,273,000 | +7.8% | 193,824 | +1.0% | 0.03% | 0.0% |
Q2 2019 | $7,677,000 | +3.0% | 191,833 | +7.6% | 0.03% | -6.1% |
Q1 2019 | $7,450,000 | +13.7% | 178,266 | +4.0% | 0.03% | 0.0% |
Q4 2018 | $6,550,000 | -5.1% | 171,408 | -0.3% | 0.03% | -5.7% |
Q3 2018 | $6,902,000 | +0.2% | 171,843 | +0.6% | 0.04% | -10.3% |
Q2 2018 | $6,888,000 | +10.8% | 170,872 | +7.4% | 0.04% | +2.6% |
Q1 2018 | $6,218,000 | +10.1% | 159,151 | -0.0% | 0.04% | +5.6% |
Q4 2017 | $5,647,000 | -10.0% | 159,214 | +3.1% | 0.04% | -20.0% |
Q3 2017 | $6,271,000 | -1.6% | 154,444 | +4.5% | 0.04% | -11.8% |
Q2 2017 | $6,373,000 | +1.6% | 147,775 | -0.7% | 0.05% | -10.5% |
Q1 2017 | $6,275,000 | +22.1% | 148,831 | +11.5% | 0.06% | +1.8% |
Q4 2016 | $5,138,000 | -9.6% | 133,432 | +1.7% | 0.06% | -30.9% |
Q2 2016 | $5,684,000 | +16.1% | 131,171 | +8.7% | 0.08% | +2.5% |
Q1 2016 | $4,894,000 | +7.0% | 120,687 | +6.5% | 0.08% | -13.2% |
Q4 2015 | $4,573,000 | +9.3% | 113,340 | +4.2% | 0.09% | -9.0% |
Q3 2015 | $4,183,000 | +2.7% | 108,801 | +11.2% | 0.10% | -5.7% |
Q2 2015 | $4,075,000 | -6.7% | 97,830 | +3.4% | 0.11% | -13.1% |
Q1 2015 | $4,367,000 | +14.2% | 94,630 | +5.8% | 0.12% | +3.4% |
Q4 2014 | $3,823,000 | -3.8% | 89,442 | +3.5% | 0.12% | -15.1% |
Q3 2014 | $3,973,000 | +7.3% | 86,412 | +24.8% | 0.14% | -3.5% |
Q2 2014 | $3,702,000 | -5.2% | 69,228 | -5.3% | 0.14% | -11.7% |
Q1 2014 | $3,906,000 | -3.1% | 73,111 | -3.1% | 0.16% | -10.9% |
Q4 2013 | $4,029,000 | +11.8% | 75,461 | +5.1% | 0.18% | -3.2% |
Q3 2013 | $3,603,000 | -2.1% | 71,818 | -2.4% | 0.19% | -14.1% |
Q2 2013 | $3,679,000 | – | 73,618 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |